Pilot Phase 2 Trial of 4 Months of Maintenance Pegylated Liposomal Doxorubicin in Patients with Advanced Ovarian Cancer after Complete Response to Platinum and Paclitaxel-Based Chemotherapy

Publisher： Karger

E-ISSN： 1423-002x|63|1|1-6

ISSN： 0378-7346

Source： Gynecologic and Obstetric Investigation, Vol.63, Iss.1, 2006-06, pp. : 1-6

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Feasibility Study on Biweekly Paclitaxel Treatment as Maintenance Chemotherapy in Advanced Müllerian Carcinoma

By  

Gynecologic and Obstetric Investigation, Vol. 73, Iss. 4, 2012-03 ,pp. : 272-276

Karger

Access to resources Recommend Favorite

Role of Extended Chemotherapy in Advanced Ovarian Cancer Patients with High Posttreatment Serum CA-125 Levels

By  

Gynecologic and Obstetric Investigation, Vol. 72, Iss. 1, 2011-03 ,pp. : 50-54

Karger

Access to resources Recommend Favorite

Optimal Debulking Surgery Followed by Paclitaxel/Platinum Chemotherapy Is Very Effective in Treating Ovarian Carcinosarcomas: A Single Center Experience

By  

Gynecologic and Obstetric Investigation, Vol. 72, Iss. 3, 2011-09 ,pp. : 208-214

Karger

Access to resources Recommend Favorite

Alteration of Telomerase Activity in Ovarian Cancer after Chemotherapy

By  

Gynecologic and Obstetric Investigation, Vol. 49, Iss. 3, 2000-04 ,pp. : 204-208

Karger

Access to resources Recommend Favorite

Use of TachoSil® to Prevent Symptomatic Lymphocele after an Aggressive Tumor Debulking with Lymphadenectomy for Advanced Stage Ovarian Cancer. A Pilot Study

By  

Gynecologic and Obstetric Investigation, Vol. 81, Iss. 6, 2016-04 ,pp. : 497-503

Karger

Access to resources Recommend Favorite